Sarepta Therapeutics, Inc. (SRPT)
NASDAQ·Healthcare·Biotechnology
$17.50
-7.85%
Mkt Cap $1.97B
Analyst Ratings
Buy
1
Hold
2
Sell
2
Price Target (71 analysts)
$21.60
Range $17.00 – $27.00
Implied Upside
+23.4%
Consensus $21.60 vs current $17.50
NASDAQ·Healthcare·Biotechnology
$17.50
-7.85%
Mkt Cap $1.97B
Buy
1
Hold
2
Sell
2
Price Target (71 analysts)
$21.60
Range $17.00 – $27.00
+23.4%
Consensus $21.60 vs current $17.50